Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

NCT07353294 · clinicaltrials.gov ↗

PHASE1

Phase

ENROLLING_BY_INVITATION

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Bladder Urothelial Carcinoma
Lymph Node Metastasis

Interventions

DRUG: propranolol
DRUG: Tislelizumab
DRUG: gemcitabine
DRUG: Cisplatin

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborators

[object Object]
[object Object]